The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
dan can tong a zhi liao ji xing nao geng si de you xiao xing he an quan xing ping jia
Author(s): 
Pages: 658-659
Year: Issue:  6
Journal: Research of Traditional Chinese Medicine

Keyword:  丹参酮ⅡA中国卒中量表巴氏指数超氧化物歧化酶丙二醛急性脑梗死;
Abstract: 目的观察丹参酮ⅡA治疗急性脑梗死的有效性和安全性。方法60例急性脑梗死病人随机分为对照组和治疗组。对照组给予急性脑梗死常规方法治疗,治疗组在常规治疗基础上加用丹参酮ⅡA治疗。两组病例于治疗前、治疗后2周分别进行巴氏指数(BI)和神经功能缺损量表(CSS)评定,并测定超氧化物歧化酶(SOD)的活性及丙二醛(MDA)的含量,观察丹参酮ⅡA治疗期间的不良反应。结果两组治疗2周后CSS和BI评分均有所改善,但治疗组改善明显优于对照组(P<0.01),两组治疗2周后血清SOD活性均升高,MDA含量均降低(P<0.05),但治疗组明显优于对照组(P<0.01),丹参酮ⅡA治疗期间无明显副反应发生。结论丹参酮ⅡA治疗急性脑梗死疗效确切,安全可靠。
Related Articles
No related articles found